CAS 957217-65-1

BTZ043 (Racemate)

CAS : 957217-65-1

Formule : C₁₇H₁₆F₃N₃O₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 431.3862

Ref: IN-DA01DBMF

BTZ043 Racemate

CAS : 957217-65-1

BTZ043 Racemate

Degré de pureté : ≥98%

Masse moléculaire : 431.39g/mol

Ref: 54-BUP10188

BTZ043 Racemate

CAS : 957217-65-1

BTZ043 Racemate (Benzothiazinone 10526038) is a decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) inhibitor, used as a new antimycobacterial agent.

Formule : C₁₇H₁₆F₃N₃O₅S

Degré de pureté : 99.516% - 99.89%

Couleur et forme : Solid

Masse moléculaire : 431.39

Ref: TM-T6425

2-(2-METHYL-1,4-DIOXA-8-AZASPIRO[4.5]DECAN-8-YL)-8-NITRO-6-(TRIFLUOROMETHYL)-4H-BENZO[E][1,3]THIAZIN-4-ONE

CAS : 957217-65-1

Degré de pureté : 98%

Masse moléculaire : 431.3900146

Ref: 10-F827254

BTZ043 Racemate

CAS : 957217-65-1

BTZ043 is a racemic mixture of two enantiomers, btz043 and btz044. It is an anti-tuberculosis drug that binds to the 50S ribosomal subunit and inhibits protein synthesis by preventing the binding of aminoacyl-tRNA to the ribosome. BTZ043 has been shown to be effective in a pharmacological study on human serum for the treatment of tuberculosis. The pharmacokinetic properties of BTZ043 have been studied in mice, with pharmacokinetic properties similar to those of nitrofurantoin. BTZ043 also has antimicrobial activity against a variety of infectious agents, including malaria, SARS coronavirus, and mycobacterium tuberculosis.br>br>

Formule : C₁₇H₁₆F₃N₃O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 431.39 g/mol

Ref: 3D-HNB21765